StonvexLoading…
StonvexStonvexStonvexCore line items from COKE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-03 | Annual 2025 2025-12-31 | Q3 2025 2025-09-26 | Q2 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $1.85B | $7.23B | $5.32B | $3.44B |
Operating Income | $237.52M | $950.66M | $708.54M | $461.90M |
Net Income | $111.56M | $570.58M | $433.33M | $291.00M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $4.39B | $4.30B | $5.67B | $5.54B |
Total Liabilities | $5.04B | $5.04B | $4.03B | $3.91B |
Cash & Equivalents | $232.95M | $281.92M | $1.53B | $1.22B |
Free Cash Flow OCF − CapEx | $142.16M | $619.59M | $512.92M | $248.84M |
Shares Outstanding | Not available | Not available | Not available | Not available |